McKesson Corporation
HealthcareNYSE:MCK · New York Stock Exchange
+$1.68 today
Vol 0.26M · Avg 1.02M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$403.4B of revenue converted into $4.8B of net income for the selected period. Gross margin is 3.6% and net margin is 1.2%, showing how much revenue survives after costs and taxes. EPS is $38.47, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $403.4B +12.4% | $359.1B +16.2% | $309.0B +11.7% | $276.7B +4.8% | $264.0B | $1.0B | $809.6M | $921.6M |
| Cost of Revenue | $388.9B +12.2% | $346.6B +16.8% | $296.7B +12.0% | $264.8B +5.4% | $251.3B | $344.8M | $725.6M | $804.0M |
| Gross Profit | $14.6B +16.5% | $12.5B +2.3% | $12.2B +2.8% | $11.9B -6.2% | $12.6B | $10.3B | $8.9B | $7.6B |
| Gross Margin | 3.6% +0.1pp | 3.5% -0.5pp | 3.9% -0.3pp | 4.3% -0.5pp | 4.8% | 45.5% | 9.8% | 28.9% |
| Research & Development | $103.0M +13.2% | $91.0M +18.2% | $77.0M -13.5% | $89.0M +27.1% | $70.0M | $378.4M | $983.2M | $1.3B |
| Selling, General & Admin | -$8.1B -200.9% | $8.0B -2.1% | $8.2B +11.9% | $7.3B -25.7% | $9.9B | $1.4B | $620.6M | $923.0M |
| Operating Expenses | $8.1B -0.2% | $8.1B -2.0% | $8.3B +11.6% | $7.4B -25.3% | $9.9B | $3.6B | $5.3B | $7.0B |
| Depreciation & Amortization | $729.0M +14.6% | $636.0M +0.2% | $635.0M -25.9% | $857.0M -14.4% | $1.0B | $1.2B | $374.2M | $1.2B |
| EBITDA | $7.2B +36.7% | $5.3B +12.5% | $4.7B -18.6% | $5.7B +84.6% | $3.1B | $12.6B | -$15.2B | $6.8B |
| EBITDA Margin | 1.8% +0.3pp | 1.5% -0.0pp | 1.5% -0.6pp | 2.1% +0.9pp | 1.2% | 10.0% | 5.6% | 46.3% |
| Operating Income | $6.5B +47.6% | $4.4B +11.3% | $3.9B -11.8% | $4.5B +63.5% | $2.7B | $10.6B | $12.3B | $14.0B |
| Operating Margin | 1.6% +0.4pp | 1.2% -0.1pp | 1.3% -0.3pp | 1.6% +0.6pp | 1.0% | 18.7% | 16.6% | 24.1% |
| Interest Income | $179.0M +3.5% | $173.0M +46.6% | $118.0M +10.3% | $107.0M +970.0% | $10.0M | $1.3B | -$1.5B | -$1.6B |
| Interest Expense | $247.0M -3.5% | $256.0M +5.3% | $243.0M -2.0% | $248.0M +39.3% | $178.0M | $969.2M | $1.1B | $1.0B |
| Other Income / Expenses | -$253.0M -1846.2% | -$13.0M +90.6% | -$138.0M -178.0% | $177.0M +122.3% | -$795.0M | -$1.6B | -$1.5B | $1.4B |
| Income Before Tax | $6.2B +42.3% | $4.4B +15.0% | $3.8B -18.2% | $4.6B +140.1% | $1.9B | -$15.6B | $3.3B | $4.9B |
| Pre-Tax Margin | 1.5% +0.3pp | 1.2% -0.0pp | 1.2% -0.4pp | 1.7% +0.9pp | 0.7% | 13.3% | 20.8% | 18.7% |
| Income Tax Expense | $1.1B +25.5% | $878.0M +39.6% | $629.0M -30.5% | $905.0M +42.3% | $636.0M | $666.8M | $1.3B | -$1.6B |
| Net Income | $4.8B +44.5% | $3.3B +9.8% | $3.0B -15.7% | $3.6B +219.6% | $1.1B | $5.0B | $4.9B | $4.8B |
| Net Margin | 1.2% +0.3pp | 0.9% -0.1pp | 1.0% -0.3pp | 1.3% +0.9pp | 0.4% | 7.4% | 12.4% | 17.5% |
| EPS (Basic) | $39 +49.1% | $26 +14.7% | $23 -10.7% | $25 +245.1% | $7 | $1.2B | $400.8M | $703.2M |
| EPS (Diluted) | $38 +49.2% | $26 +14.9% | $22 -10.6% | $25 +246.3% | $7 | $620.6M | $766.2M | $609.4M |
| Weighted Avg Shares | $123.6M -3.0% | $127.4M -4.4% | $133.2M -5.6% | $141.1M -7.4% | $152.3M | $892.2M | $757.8M | $925.8M |
| Weighted Avg Shares (Diluted) | $124.1M -3.1% | $128.1M -4.5% | $134.1M -5.7% | $142.2M -7.7% | $154.1M | $319.6M | $1.2B | $924.4M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
CVS Health Corporation
NYSE:CVS
$129.99B
Stryker Corporation
NYSE:SYK
$119.99B
Bristol-Myers Squibb Company
NYSE:BMY
$116.51B
Vertex Pharmaceuticals Incorporated
NASDAQ:VRTX
$112.63B
GSK plc
NYSE:GSK
$106.57B
Sanofi
NASDAQ:SNY
$106.49B
Medtronic plc
NYSE:MDT
$103.02B
HCA Healthcare, Inc.
NYSE:HCA
$85.82B
Cencora, Inc.
NYSE:COR
$54.79B
Cardinal Health, Inc.
NYSE:CAH
$52.49B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does MCK generate?
McKesson Corporation (MCK) reported $403.43B of revenue in fiscal 2026.
Is MCK profitable?
McKesson Corporation (MCK) reported $4.76B of net income, with a net margin of 1.2%.
Explore More
Continue the stock analysis
Jump to another research area for this company.